A new vaccine against advanced cutaneous melanoma will be available to UK patients through an NHS program
Sanziana Georgescu
Health
sursa foto: pexels.com
Always see our news on Google
<p>The UK's National Health Service is launching an innovative vaccine, iSCICIB1+, for patients with advanced cutaneous melanoma to improve the immune system's response to immunotherapy treatments. The program, part of the Cancer Vaccine Launch Pad, will enable rapid access to clinical trials, targeting 10,000 patients by 2030. The first patients are expected to start treatment next month, and the initiative highlights the potential of vaccines to transform cancer care and save lives. Melanoma is the fifth most common cancer in the UK and early monitoring is essential for effective treatment.
Sources
Latest News
22:54
Iulia Navalnaya urges Russians to vote for Yabloko: the September elections, a legal referendum against the war
22:39
The air forces of Bulgaria, Romania, and Spain have signed a trilateral agreement for air policing operations within NATO.
22:30
The government has approved the 'Diaspora Invests at Home' program, which offers grants of up to 200,000 euros to Romanians from the Diaspora for businesses in Romania.
22:22
The crisis in Ceuta unites the Spanish extremes: Sumar and Vox demand the exclusion of Morocco from the 2030 World Cup.
22:14
At the County Emergency Hospital in Miercurea Ciuc, the first two prostate cancer surgeries were performed with the help of the Da Vinci robotic system.
See more news
NEWS ON THE SAME TOPICS
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
